These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16767382)

  • 1. Neovascularization of the optic disc in Behçet's disease.
    Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Kir N; Urgancioglu M
    Jpn J Ophthalmol; 2006; 50(3):256-65. PubMed ID: 16767382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal and disc neovascularization in Behçet's disease and efficacy of laser photocoagulation.
    Atmaca LS; Batioğlu F; Idil A
    Graefes Arch Clin Exp Ophthalmol; 1996 Feb; 234(2):94-9. PubMed ID: 8720678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of optic disc neovascularization in patients with Behçet's uveoretinitis after infliximab therapy.
    Kawaguchi T; Sugita S; Yamada Y; Miyanaga M; Mochizuki M
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):627-30. PubMed ID: 21043804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy.
    Keino H; Okada AA; Watanabe T; Taki W
    Br J Ophthalmol; 2011 Sep; 95(9):1245-50. PubMed ID: 21183514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of interferon alpha-2a therapy in patients with Behcet's disease.
    Yalçindağ FN; Uzun A
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):439-43. PubMed ID: 22455657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tractional retinal detachment after branch retinal vein occlusion. Influence of disc neovascularization on the outcome of vitreous surgery.
    Ikuno Y; Ikeda T; Sato Y; Tano Y
    Ophthalmology; 1998 Mar; 105(3):417-23. PubMed ID: 9499770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments.
    Sobaci G; Erdem U; Durukan AH; Erdurman C; Bayer A; Köksal S; Karagul S; Bayraktar MZ
    Ophthalmology; 2010 Jul; 117(7):1430-5. PubMed ID: 20417563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.
    Kötter I; Eckstein AK; Stübiger N; Zierhut M
    Br J Ophthalmol; 1998 May; 82(5):488-94. PubMed ID: 9713053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of Behçet's disease in the Indian population.
    Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
    Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.
    Ophthalmology; 1993 Nov; 100(11):1655-64. PubMed ID: 8233391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.
    Bodaghi B; Gendron G; Wechsler B; Terrada C; Cassoux N; Huong du LT; Lemaitre C; Fradeau C; LeHoang P; Piette JC
    Br J Ophthalmol; 2007 Mar; 91(3):335-9. PubMed ID: 17050581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.
    Wechsler B; Bodaghi B; Huong DL; Fardeau C; Amoura Z; Cassoux N; Piette JC; LeHoang P
    Ocul Immunol Inflamm; 2000 Dec; 8(4):293-301. PubMed ID: 11262659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with photocoagulation in Behçet's disease.
    Atmaca LS
    Ophthalmic Surg; 1990 Aug; 21(8):571-6. PubMed ID: 2234807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a].
    Deuter CM; Kötter I; Günaydin I; Zierhut M; Stübiger N
    Ophthalmologe; 2004 Feb; 101(2):129-34. PubMed ID: 14991308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neovascularization of the optic disc associated with obstruction of the central retinal artery.
    Duker JS; Brown GC
    Ophthalmology; 1989 Jan; 96(1):87-91. PubMed ID: 2465522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular Manifestations, Conventional Fundus Fluorescein Angiographic Findings, and Relationship Between Angiographic Findings and Visual Acuity in Behçet's Disease.
    Bazvand F; Zarei M; Ebrahimiadib N; Karkhaneh R; Davoudi S; Soleimanzadeh M; Sharifian E; Roohipoor R; Modjtahedi BS
    Semin Ophthalmol; 2017; 32(6):764-771. PubMed ID: 27715380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal tears associated with panuveitis and Behçet's disease.
    Akova YA; Yilmaz G; Aydin P
    Ophthalmic Surg Lasers; 1999; 30(9):762-5. PubMed ID: 10574500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior segment involvement in ocular Behçet's disease.
    Ozdal PC; Ortaç S; Taşkintuna I; Firat E
    Eur J Ophthalmol; 2002; 12(5):424-31. PubMed ID: 12474927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Retinal Neovascularization in Proliferative Diabetic Retinopathy Imaged by Optical Coherence Tomography Angiography.
    Ishibazawa A; Nagaoka T; Yokota H; Takahashi A; Omae T; Song YS; Takahashi T; Yoshida A
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6247-6255. PubMed ID: 27849310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet's disease.
    Gedik S; Akova Y; Yilmaz G; Bozbeyoğlu S
    Ocul Immunol Inflamm; 2005 Feb; 13(1):51-8. PubMed ID: 15804770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.